Fujifilm Diosynth Biotechnologies: TG Therapeutics Has Committed to a Multi-Year Manufacturing Supply Agreement for Briumvi® (Ublitiximab-Xiiy), Its U.S. FDA-Approved Therapeutic for Relapsing Forms of Multiple Sclerosis (Rms)
Fujifilm Diosynth生物技術：tg therapeutics已承諾爲其在美國獲得FDA批准的復發型多發性硬化症（rms）療法Briumvi®（Ublitiximab-Xiiy）達成多年的製造供應協議
